Posted by ABMN Staff on May 17th, 2024
Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) CEO Paul J. Diaz sold 75,000 shares of the stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $25.07, for a total value...
More of this article »